Change in Control Notice Clause Samples

Change in Control Notice. 1.2 Notice of an Event of Force Majeure;

Change in Control Notice. The Bank agrees to give Executive at least 60 days advance written notice ("Change in Control Notice") of any proposed or anticipated Change in Control or, if it is not practicable for the Bank to give Executive at least 60 days advance notice, then the Bank shall give Executive a Change in Control Notice as soon as practicable in the circumstances. For purposes of the calculations in Section 4, the Bank will be deemed to have given Executive a Change in Control Notice on the date (the "Change of Control Notice Date") that is the earliest of: (i) the date it actually gives Executive a Change in Control Notice, (ii) a transaction that could result in a Change in Control is approved by the Bank Board, the Holding Company Board, or the Company's Shareholders, if Executive has actual knowledge of such approval or is given notice (stating that such transaction will be considered at such meeting) of the meeting; (iii) a transaction that could result in a Change in Control is considered at a meeting of the Bank Board, the Holding Company Board, or the Holding Company's Shareholders if Executive attends or is given notice (stating that such transaction will be considered at such meeting) of the meeting; or (iv) an application for approval of a Change in Control is submitted to any government regulatory agency (the approval of which is required to effectuate a Change in Control) if Executive has actual notice that such an application is submitted.

Change in Control Notice. Borrowers shall provide Lender with 30 day written notice prior to any Change in Control, specifying in reasonable detail the event or transaction expected to cause such Change in Control (the “Change in Control Notice”).

Change in Control Notice. A notice from IHCC delivered pursuant to Section 15.3. Change in Control Transaction. A transaction or series of transactions in which a party that is not an Affiliate of Dynex Capital will acquire more than twenty-five percent (25%) of the voting securities of Dynex Capital to be outstanding after that transaction or series of transactions. Code. The United States Internal Revenue Code of 1986, as amended, and any successor statute thereto. Commercial Capital Access One, Inc., a Virginia corporation, together with its successors and assigns. Company. Copperhead Ventures, LLC. Company Business. The business of the Company described in Section 4. Company Minimum Gain. As of any date, the amount determined under Regulations Sections 1.704-2(b)(2) and 1.704-2(d).

Change in Control Notice. 3.1. During the period beginning on the Closing Date and ending on the 18-month anniversary of the Closing Date (or, if there is no corresponding date in such calendar month, then the last day of such calendar month) (the “CIC Notification Period”), the Company grants Astellas a right of notification with respect to a Change in Control, as set forth in Section 3.2 and subject to the terms and conditions set forth in this Letter Agreement. For purposes of this Letter Agreement, the term “Change in Control” means (i) a consolidation, merger or similar transaction of the Company with or into any other corporation or other entity or Person (as defined in the Purchase Agreement), except for any such consolidation, merger or similar transaction involving the Company in which the shares of capital stock of the Company outstanding immediately prior to such consolidation, merger or similar transaction continue to represent, or are converted into or exchanged for shares of capital stock that represent, immediately following such consolidation, merger or similar transaction, a majority, by voting power, of the capital stock of (a) the surviving or resulting corporation, or (b) if the surviving or resulting corporation is a wholly owned subsidiary of another corporation immediately following such consolidation, merger or similar transaction, the parent corporation of such surviving or resulting corporation; (ii) any transaction or series of related transactions in which fifty percent (50%) or more of the Company’s voting power is transferred or becomes beneficially owned by any Person or group; or (iii) the sale or transfer of all or substantially all of the Company’s assets or the exclusive, worldwide license of all or substantially all of the Company intellectual property related to the Company’s cell therapy programs that is material to the Company and its subsidiaries, taken as a whole.